Pharmacy Market Analysis

Type Segment Analysis

Prescription drugs segment is predicted to garner the largest share of 63.5% in the pharmacy market during the forecast timeline. The rising disease prevalence and growing demand for specialty therapies are the key factors reinforcing the segment’s dominance in this field. This can be testified by the CDC survey of National Health Statistics Reports published in September 2024 that observed that in the U.S., 88.6% of adults who are aged above 65 took prescription drugs from 2021 to 2022, with higher use among those with chronic conditions, hence denoting a wider segment scope.

Distribution Channel Segment Analysis

Retail pharmacy segment is projected to experience a lucrative growth in the market by the end of 2035. The segment’s growth is subject to extensive physical presence, expanded consultation services, and immediate access. Also, the profitable collaborations between organizations are blooming growth in the segment. In February 2025, CVS Pharmacy, in collaboration with Duquesne University, declared the launch of a Tuition Advantage program to address the national pharmacist shortage.  It also underscored that the initiative offers reduced-cost Pharm.D. education to CVS employees, strengthening the retail pharmacy segment by improving staffing and service accessibility.

Therapeutic Area Segment Analysis

Cardiovascular segment is expected to grow with a significant share in the pharmacy market during the discussed timeline. The growth in the segment originates from increasing disease occurrence, personalized interventions, and medication adherence programs. Therefore, the study published by WHO in July 2025 outlined that increased access to essential medications such as aspirin, beta-blockers, ACE inhibitors, statins, and others is highly essential for management of timely and efficient management of cardiovascular diseases, hence denoting a positive market outlook.

Our in-depth analysis of the global market includes the following segments: